Literature DB >> 33331327

[Rheumatoid arthritis combined with pigmented villonodular synovitis: A case report and literature review].

J J Peng, T Liu.   

Abstract

We reported a case of rheumatoid arthritis (RA) combined with pigmented villonodular synovitis (PVNS) from Peking University People's Hospital. The clinical data were introduced and the related literature was reviewed. The clinical features, treatment and prognosis of the disease were summarized to improve clinicians' understanding of this rare disease and avoid misdiagnosis and delayed diagnosis. A 45-year-old female, with 15 years of RA history and unregular treatment, was admitted to the hospital with the complaint of aggravating pain and swelling in the right knee for 3 months. The puncture of the right knee was performed and there was a large amount of bloody synovial fluid that could not be explained by her RA history. Moreover, the magnetic resonance imaging (MRI) of the right knee revealed hemosiderin deposition with low-intensity signals on both T1-weighted and T2-weighted images which suggested PVNS to us. Then, the patient underwent knee arthroscopy and biopsy to assist in diagnosis. The arthroscopic appearance and pathology were consistent with PVNS and the hyperplastic synovium was removed during arthroscopy. After the operation, she did active functional exercises and took disease-modifying antirheumatic drugs to control RA. She recovered well and remained asymptomatic after half a year of follow-up. Also, there was no recurrence of the right knee. As we all know, RA is a systemic autoimmune disease characterized by chronic synovitis and joint damage. And PVNS is characterized by synovial proliferation and infiltrative process. Both of them are synovial involvement and the clinical manifestations are quite similar. PVNS has occasionally been reported in association with RA. So it is difficult to make a clear diagnosis of RA combined with PVNS. Literature was searched with RA+PVNS in the WanFang Medical Network Database and China National Knowledge Infrastructure and there were no related Chinese cases. Then we searched literature from PubMed with RA+PVNS. The cases were still rare and eventually 2 related articles were yielded including 2 similar patients. It is necessary to fully understand the disease development, complicated MRI appearance and various pathological morpho-logy. They can contribute to making a correct diagnosis which is effective to guide the proper treatment.

Entities:  

Keywords:  Hemarthrosis; Pigmented villonodular synovitis; Rheumatoid arthritis; Synovial fluid

Mesh:

Year:  2020        PMID: 33331327      PMCID: PMC7745269     

Source DB:  PubMed          Journal:  Beijing Da Xue Xue Bao Yi Xue Ban        ISSN: 1671-167X


  20 in total

Review 1.  Unusual Findings in Synovial Fluid Analysis: A Review.

Authors:  Francesca Oliviero; Paola Galozzi; Roberta Ramonda; Felipe Leite de Oliveira; Franco Schiavon; Anna Scanu; Leonardo Punzi
Journal:  Ann Clin Lab Sci       Date:  2017-05       Impact factor: 1.256

Review 2.  Molecular pathways involved in synovial cell inflammation and tumoral proliferation in diffuse pigmented villonodular synovitis.

Authors:  U Fiocco; P Sfriso; F Lunardi; E Pagnin; F Oliviero; E Scagliori; L Cozzi; M Vezzù; B Molena; A Scanu; C Panziera; R Nardacchione; L Rubaltelli; J M Dayer; F Calabrese; L Punzi
Journal:  Autoimmun Rev       Date:  2010-07-08       Impact factor: 9.754

3.  Neue Definitionen der Integrativen Medizin: Alter Wein in neuen Schläuchen?

Authors:  Tobias Esch; Benno Brinkhaus
Journal:  Complement Med Res       Date:  2020-03-23       Impact factor: 1.211

4.  Pigmented villonodular synovitis and tenosynovitis: a clinical epidemiologic study of 166 cases and literature review.

Authors:  B W Myers; A T Masi
Journal:  Medicine (Baltimore)       Date:  1980-05       Impact factor: 1.889

5.  Long-term outcome of knee arthroplasty in the setting of pigmented villonodular synovitis.

Authors:  Matthew T Houdek; Maurizio Scorianz; Cody C Wyles; Robert T Trousdale; Franklin H Sim; Michael J Taunton
Journal:  Knee       Date:  2017-05-25       Impact factor: 2.199

Review 6.  Localized and diffuse forms of tenosynovial giant cell tumor (formerly giant cell tumor of the tendon sheath and pigmented villonodular synovitis).

Authors:  F Gouin; T Noailles
Journal:  Orthop Traumatol Surg Res       Date:  2017-01-02       Impact factor: 2.256

7.  Pigmented villonodular synovitis (PVNS) of the knee joint: magnetic resonance imaging (MRI) using standard and dynamic paramagnetic contrast media. Report of 52 cases surgically and histologically controlled.

Authors:  Antonio Barile; Mylene Sabatini; Francesca Iannessi; Ernesto Di Cesare; Alessandra Splendiani; Vittorio Calvisi; Carlo Masciocchi
Journal:  Radiol Med       Date:  2004-04       Impact factor: 3.469

Review 8.  Pigmented villonodular synovitis developing in a patient with rheumatoid arthritis.

Authors:  Xia Zhao; Wei Ji; Xian Qian; Yan Lu
Journal:  J Clin Rheumatol       Date:  2014-08       Impact factor: 3.517

Review 9.  Diffuse-type tenosynovial giant cell tumour: Current treatment concepts and future perspectives.

Authors:  Eric L Staals; Stefano Ferrari; Davide M Donati; Emanuela Palmerini
Journal:  Eur J Cancer       Date:  2016-06-05       Impact factor: 9.162

Review 10.  Pexidartinib (TURALIO™): The First FDA-Indicated Systemic Treatment for Tenosynovial Giant Cell Tumor.

Authors:  Shanada Monestime; Dovena Lazaridis
Journal:  Drugs R D       Date:  2020-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.